(Q46514203)

22 December 2017

title

Efficacy of two different platinum- or anthracycline-containing chemotherapy regimens for the treatment of small cell lung cancer (English)

1 reference

22 December 2017

author name string

Tassinari D

1

1 reference

22 December 2017

Genestreti G

2

1 reference

22 December 2017

Pasquini E

3

1 reference

22 December 2017

Papi M

4

1 reference

22 December 2017

Fantini M

5

1 reference

22 December 2017

Tamburini E

6

1 reference

22 December 2017

Fochessati F

7

1 reference

22 December 2017

Poggi B

8

1 reference

22 December 2017

Imola M

9

1 reference

22 December 2017

Mianulli AM

10

1 reference

22 December 2017

Fattori PP

11

1 reference

22 December 2017

Lazzari-Agli L

12

1 reference

22 December 2017

Ioli G

13

1 reference

22 December 2017

Sartori S

14

1 reference

22 December 2017

Ravaioli A

15

1 reference

22 December 2017

publication date

1 April 2005

1 reference

22 December 2017

published in

Journal of Chemotherapy

1 reference

22 December 2017

volume

17

1 reference

22 December 2017

page(s)

228-236

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.228

Discrepancies between meta-analyses and subsequent large randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.228

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.228

The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.228

Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.228

Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.228

Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.228

Irinotecan in small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.2.228

10.1179/JOC.2005.17.2.228

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15920911

1 reference

22 December 2017